Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/49454
Title: | Cardiovascular medicines : comparative costs and benefits |
Authors: | Cardona, Mark Vella, John Zarb Adami, Maurice Azzopardi, Lilian M. Serracino-Inglott, Anthony |
Keywords: | Cardiovascular Agents -- Costs -- Malta Cardiovascular Agents -- Economic aspects Cardiovascular pharmacology Generic drugs -- Malta |
Issue Date: | 2013-08 |
Publisher: | University of Malta. Department of Pharmacy |
Citation: | Cardona, M., Vella, J., Zarb Adami, M., Azzopardi, L. M., & Serracino-Inglott, A. (2013, August). Cardiovascular medicines: comparative costs and benefits. Poster session presented at the International Pharmaceutical Federation (FIP) World Congress, Dublin, Ireland. |
Abstract: | A poster presentation regarding Cardiovascular medicines: comparative costs and benefits. Introduction: An increase in global life expectancy and a concomitant shift in population demographics is leading to a greater incidence of non-communicable disease, with cardiovascular(CVA) morbidity being the primary cause of death worldwide. In 2010, 17.3 million deaths and €863 million in healthcare interventions were attributed to CVA disease at a global level. With the same trends exhibiting themselves locally, consideration of the cost of treatment and financial factors was a topical issue. Aims: • Obtain the costs of all cardiovascular drugs found in the local private retail community setting • Analyse the prices of generic and proprietary products and derive a relationship • Observe the effect of a price differential for equivalent products to their sales volume over time. |
URI: | https://www.um.edu.mt/library/oar/handle/123456789/49454 |
Appears in Collections: | Scholarly Works - FacM&SPha |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Cardiovascular_medicines_comparative_costs_and_benefits_2013.pdf | 410.93 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.